Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Mar 5;15(3):e0230111. doi: 10.1371/journal.pone.0230111

Exploring the effect of hypertension on retinal microvasculature using deep learning on East Asian population

Guangzheng Dai 1,2, Wei He 1,2,3,*, Ling Xu 2,3, Eric E Pazo 2,3, Tiezhu Lin 2,3, Shasha Liu 2, Chenguang Zhang 1,2
Editor: Frank T Spradley4
PMCID: PMC7058325  PMID: 32134976

Abstract

Hypertension is the leading risk factor of cardiovascular disease and has profound effects on both the structure and function of the microvasculature. Abnormalities of the retinal vasculature may reflect the degree of microvascular damage due to hypertension, and these changes can be detected with fundus photographs. This study aimed to use deep learning technique that can detect subclinical features appearing below the threshold of a human observer to explore the effect of hypertension on morphological features of retinal microvasculature. We collected 2012 retinal photographs which included 1007 from patients with a diagnosis of hypertension and 1005 from normotensive control. By method of vessel segmentation, we removed interference information other than retinal vasculature and contained only morphological information about blood vessels. Using these segmented images, we trained a small convolutional neural networks (CNN) classification model and used a deep learning technique called Gradient-weighted Class Activation Mapping (Grad-CAM) to generate heat maps for the class “hypertension”. Our model achieved an accuracy of 60.94%, a specificity of 51.54%, a precision of 59.27%, and a recall of 70.48%. The AUC was 0.6506. In the heat maps for the class “hypertension”, red patchy areas were mainly distributed on or around arterial/venous bifurcations. This indicated that the model has identified these regions as being the most important for predicting hypertension. Our study suggested that the effect of hypertension on retinal microvascular morphology mainly occurred at branching of vessels. The change of the branching pattern of retinal vessels was probably the most significant in response to elevated blood pressure.

Introduction

Cardiovascular diseases are the world’s biggest killers and these diseases have remained the leading causes of death globally in the last 15 years [1]. Hypertension is the leading modifiable risk-factor, which affects 23.2% (estimated 244.5 million) of Chinese adult population aged ≥18 years [2]. There is evidence that elevated blood pressure has a substantial impact on the microvasculature in end-organs, such as the brain, heart, kidney, eye and so on [37]. In particular, retinal vasculature, measuring 100 to 300 μm in size, has attracted a lot of non-ophthalmological attention. Retinal microvascular abnormalities represent a manifestation of ongoing systemic microvascular damage and can be viewed directly and noninvasively, offering a unique and easily accessible “window” to study the human microcirculation in vivo. Advances in digital retinal photography and computer image analysis have now enabled more objective quantitative assessment of retinal microvascular structure and function, and may offer a potential noninvasive research tool to assess the pathophysiology of hypertension.

Extensive researches on retinal microvascular phenotypes in fundus images have shown that hypertension can lead to abnormal signs on retina [828]. These abnormal signs can be broadly divided into four groups: classic hypertensive retinopathy, isolated retinopathy (e.g., retinal hemorrhage, microaneurysm, or cotton wool spot), changes from retinal vascular caliber (e.g., generalized retinal arteriolar narrowing, focal arteriolar narrowing, arteriovenous nicking), and changes from retinal vascular architecture (e.g., retinal tortuosity, fractal dimension, branching angle). These signs probably reflect systemic microvascular damage and may be an early indicator of cardiovascular diseases. In addition, some prospective studies suggest that retinal microvascular abnormal signs are predictive of the subsequent risk of hypertension independently of other known risk factors [2935]. Although a large number of studies have reflected the association between abnormal retinal microvascular signs and hypertension, some results were inconsistent with three reasons. Firstly, qualitative assessment of hypertensive retinopathy is mainly based on the experiences of the individual and the evaluation results lacks objectivity. Secondly, there is a variety of methods of computer-assisted quantification of retinal vasculature, such as retinal vessel caliber, and thus measurements given for the same fundus image often vary. Last but not least, variations in image brightness, focus, and contrast can significantly affect the measurement of retinal vasculature.

Thus this study was designed to analyze retinal image using convolutional neural networks (CNN), also known as convnets, a type of deep-learning model almost universally used in computer vision applications. One fundamental characteristic of convnets that is composed of multiple processing layers is that it can find interesting features in training data on its own, without any need for manual feature engineering [36]. This is especially useful in problems where the input samples are very high-dimensional, like retinal fundus images. It can detect subclinical and discrete features appearing below the threshold of a human observer and quantify minimal differences in feature expression. Recently, a CNN was trained on fundus images to screen DR [3742] or age-related macular degeneration [43]. Moreover, a more sophisticated CNN (Google Inceptionv3) has been trained on datasets from the UK Biobank [44] and EyePACS [45] cohorts to detect cardiovascular risk factors from retinal images such as age, gender, hypertension, and smoking status [46]. In this paper, we have constructed an automated segmentation model to delineate retinal vascular structure of fundus photographs and introduced visualization technique to further explore pathophysiological changes of retinal microvasculature in hypertensive patients.

Materials and methods

Data collection

The research followed the tenets of the Declaration of Helsinki and was reviewed by the Committee on Medical Ethics of Shenyang He Eye Hospital. We collected 735 patients (1007 eyes) with a diagnosis of hypertension and 684 normotensive control subjects (1005 eyes), who were admitted between May 2017 and December 2018 to Shenyang He Eye Hospital with eye disease. The case group included 274 males and 461 females, mean age 66.47 ± 9.06 years (from 29 to 92 years), whereas the control group was composed of 326 males and 358 females, mean age 61.27 ± 10.48 years (from 31 to 88 years). Age of hypertension group was higher than control group (P < 0.001), and the proportion of women is higher (P < 0.001). Individual written informed consent could not be obtained, because all the subjects were admitted to Shenyang He Eye Hospital in 2017–2018 and most of them could not be contacted. In addition, our dataset did not contain any patient identification information. We applied to the Committee on Medical Ethics for exemption from informed consent and obtained permission.

Each patient underwent ophthalmological examination and standard assessments of cardiovascular risk factors. Retinal photographs that were centered on the macula and documented the optic disc, the macula, substantial portions of the temporal vascular arcades were taken with 45°non-mydriatic digital camera (TRC-NW300, Topcon, Tokyo, Japan) after dilation of the pupils with tropicamide phenylephrine eye drops. Hypertension was defined as systolic blood pressure greater than 140 mm Hg, diastolic blood pressure above 90 mmHg, or use of antihypertensive medication during the previous 2 weeks. Exclusion criteria were: diabetes mellitus that was defined as a fasting blood glucose concentration above 7.0 mmol/L, a non-fasting value of more than 11.1 mmol/L, or a self-reported history of treatment for diabetes; poor dilation or ocular media opacities so that part of or the entire retinal vessel is almost indiscernible (e.g., cataracts with high-severity opacity of lens, vitreous hemorrhage); any other previous or coexisting ocular disease that could affect the retinal vasculature (e.g., glaucoma, central or branch retinal artery occlusion, central or branch retinal vein occlusion).

Image preprocessing

The JPEG content was decoded to RGB grids of pixels at a size of 2048×1536. For pre-processing, auto-cutting was employed to minimize black borders around the field of view and yields square images, of dimension1496×1496, in order to scale the images without distortion. And then all images were resized to 565×565. To highlight the retinal vasculature, two image enhancement methods, gamma correction and contrast limited adaptive histogram equalization (CLAHE), were conducted to enhance the image contrast, and “enhanced dataset” was obtained (Figs 1 and 2).

Fig 1. Examples of fundus photographs from normotensive subjects.

Fig 1

Top row: Raw retinal images. Middle row: enhanced images. Bottom row: segmented blood vessel images.

Fig 2. Examples of fundus photographs from hypertension patients.

Fig 2

Top row: Raw retinal images. Middle row: enhanced images. Bottom row: segmented blood vessel images.

CLAHE is a computer image processing technique used to improve the image contrast [47]. Briefly, it computes several histograms corresponding to distinct sections of the image and limits the amplification by clipping the histograms at a predefined value, and uses them to redistribute the lightness values of the image. It is therefore suitable for improving the local contrast of an image and bringing out more detail.

Gamma correction is a nonlinear mapping of the gray value of the input image and can be expressed by the equation [48].

Iγ=pIγ

I is the input intensity, Iγ is the output intensity, and p is a normalization factor which is determined by the value ofγ. In this study, the setting of γ is equal to 1/1.2, and the overall brightness of the image is improved, while the contrast at the low gray level is increased, which is more conducive to the image details at the low gray level.

Retinal vessel segmentation

The vessel segmentation task was based on an open source hosted at GitHub [49]. Briefly, the automated vessel segmentation model is derived from the U-Net architecture [50] and was trained on DRIVE (digital retinal images for vessel extraction) dataset. The DRIVE is a publicly available database, containing a total of 40 colored fundus photographs obtained from a diabetic retinopathy (DR) screening program in the Netherlands [51]. There are 20 images used for training and the rest 20 for testing by default. The performance of this segmentation model is tested on the DRIVE database, and it achieves 0.9790 of area under the ROC curve. On STARE database, it achieves 0.9805 of area under the ROC curve. We used the automated segmentation model to extract retinal vessels of every fundus image of “enhanced dataset”, and “segmented dataset” was obtained (Figs 1 and 2).

Classification model development

A small CNN architecture that was used for training and classification in our project is presented below Fig 3. In short, five convolution layers, five pooling layers and two fully-connected layers composed the main body of CNN. To prevent overfitting, the size of the model, namely learnable parameters in the model, was reduced as much as possible. The number of filters in the convolution layers and the number of units in the densely-connected layers was set to a smaller value and global max pooling layer was used after the last convolution layer. Batchnormalization layers were used for accelerating converge, and dropout layers were added to combat overfitting.

Fig 3. CNN architecture.

Fig 3

f: number of filters; k: kernel size; s: strides; p: pool size; u: number of units; r: fraction of the input units to drop.

For either of the two datasets (“enhanced dataset” and “segmented dataset”), all fundus images with one target label: hypertension-status (Yes/No) were randomly partitioned into five equal sized subsamples. Of the five subsamples, a single subsample was retained as the “test set” which was not used during the training process to test the model, and the remaining four subsamples are used as the “development set” to develop our model. The training process was then repeated five times.

During the training process, the “development set” was divided into a training set (75%) and a validation set (25%) which was a random subset of the “development set” and was not used to train the model parameters, but was used as a small evaluation dataset for tuning the model. The training set was resized to 256×256, and via a number of random transformations, which include adjusting the brightness of images by random factor, flipping images horizontally or vertically, randomly cropping images to 224×224, yielded a number of believable-looking images. Thus, at each iteration, the model never saw the exact same picture twice. This helps expose the model to more aspects of the data and generalize better. The validation set were resized to 224×224, and data augmentation techniques was not applied during the validation process.

All codes employed in our study were executed in the tensorflow2.0 framework with Windows10 + CUDA (Compute Unified Device Architecture) 10.0. Experiments were run in an Intel Core i9-9900K CPU @ 3.60 GHz with 32.0 GB of RAM memory and a NVIDIA GeForce RTX 2080.

Evaluating the model

Due to the small sample size of the dataset, five-fold cross-validation was adopted. The cross-validation process was repeated five times, and the five results were averaged to produce a single estimation. In order to keep the image size consistent with cropped pictures during the training process, all testing images were resized to 224×224. To evaluate performances of the learned model, we adopted several evaluation parameters, including accuracy, specificity, precision, recall, and the area under the receiver operating characteristic curve (AUC).

Accuracy=TP+TNTP+TN+FP+FN
Specificity=TNTN+FP
Precision=TPTP+FP
Recall=TPTP+FN

TP represents correctly classified hypertension images and TN represents correctly classified non-hypertension images. FP represents false positive values, where non-hypertension images are wrongly classified as hypertension and FN represents false negative values where hypertension images are wrongly classified as non-hypertension.

Visualizing heat maps of class activation

To better understand which parts of a given retinal photograph led a CNN to its final classification decision, we used a deep learning technique called Gradient-weighted Class Activation Mapping (Grad-CAM) [52]. This approach uses the gradients of target concept, flowing into the final convolutional layer to produce a coarse localization map highlighting the important regions in the image for predicting the concept. Heat maps for the class“hypertension” or “non-hypertension” were generated from the “segmented dataset” as images from this dataset contained only morphological attributes of retinal blood vessels, such as length, width, tortuosity and branching pattern. After removing interference information other than blood vessels, we can accurately find the effect of hypertension on retinal blood vessels.

Results and discussion

Results

Both “enhanced dataset” and “segmented dataset” were used independently, to train and test a CNN model. Although methods, such as reducing the size of the model, using dropout layers, and data augmentation techniques were used, these couldn’t entirely eliminate overfitting. For “enhanced dataset”, with the decreasing of the training loss (cross-entropy loss between true labels and predict labels), the drop in validation loss is quite small. The three hundred epochs training-stop criterion was chosen as it was observed that the model validation loss started stalling (or increasing) after 300 epochs of training. For “segmented dataset”, the model started overfitting, and its performance degrades more slowly once it starts overfitting. The five hundred epochs training-stop criterion was chosen as it started stalling (or increasing) after 500 epochs of training.

For “enhanced dataset”, averaged the results of the five cross-validation and our model achieved an accuracy of 56.76%, a specificity of 63.80%, a precision of 58.97%, and a recall of 49.93%. The AUC was 0.6069. For “segmented dataset”, our model produced an improved accuracy 60.94% and recall 70.48%, a similar precision 59.27%, but its specificity dropped to 51.54%. Finally, the AUC was 0.6506 (Table 1).

Table 1. The performance of the model on two different dataset.

enhanced dataset segmented dataset
Accuracy 53.35% 56.47% 57.21% 59.31% 57.46% 58.31% 60.20% 63.68% 59.31% 63.18%
Average 56.76% Average 60.94%
Specificity 51.04% 56.48% 76.44% 80.32% 54.73% 52.60% 48.61% 54.81% 49.47% 52.23%
Average 63.80% Average 51.54%
Precision 55.45% 52.76% 59.17% 70.40% 57.08% 59.56% 55.24% 60.17% 60.58% 60.82%
Average 58.97% Average 59.27%
Recall 55.45% 56.45% 36.60% 40.93% 60.20% 63.51% 73.66% 73.20% 67.91% 74.13%
Average 49.93% Average 70.48%
AUC 0.5572 0.6144 0.6083 0.6532 0.6014 0.5893 0.6634 0.6655 0.6558 0.6789
Average 0.6069 Average 0.6506

Using the “segmented dataset”, the learned model had the highest prediction precision for hypertension at the last time of repeated cross-validation. So we used the model trained from the last cross-validation and corresponding “test set” to produce heat maps for the class “hypertension” and “non-hypertension”. There are two hundred and fifty heat maps of class activation, one hundred and thirty-six from correctly classified hypertension images and one hundred and fourteen from correctly classified non-hypertension images, and representative examples are shown in Figs 4 and 5. For heat maps for the class “hypertension”, red patchy areas that were strongly activated showed discrete distribution, and most of them were on or around arterial/venous bifurcations. This is how the network can tell the difference of retinal microvascular morphology between hypertension and non-hypertension. But, for heat maps for the class “non-hypertension”, red areas showed a continuous distribution along the blood vessels.

Fig 4. Heat maps for the class “hypertension”.

Fig 4

Arterial/venous bifurcations were within the black ring.

Fig 5. Heat maps for the class “non-hypertension”.

Fig 5

Discussion

In our study, the dataset size was small for deep learning. Although we use some strategies for mitigating overfitting and maximizing generalization, such as reducing the size of the model, using dropout layers, and data augmentation, the model eventually started over-fitting after a certain number of iterations. Because these techniques couldn't produce new information and could only remix existing information—the inputs the model sees are still heavily inter-correlated. So we interrupted the training process when the validation loss was no longer improving. Using “segmented dataset”, the accuracy and the precision of the model on the “test set” is slightly higher than using “enhanced dataset”, and the recall and the AUC is apparently higher. However, it had a lower specificity. The possible reason was that the information of leading the model to hypertension decision mainly came from retinal microvasculature, while the information about non-hypertension also came from other parts of the images other than the blood vessels. Images from “segmented dataset” that contained only retinal blood vessels more likely to be identified as high blood pressure, therefore the recall is higher and the specificity is lower.

To better understand the effect of hypertension on phenotypic traits of retinal microvasculature, we used the images that contained only retinal blood vessels to produce heat maps. As shown in Fig 4, red patchy areas in the heat maps for the class “hypertension” were mainly distributed on or around arterial/venous bifurcations. This indicated that the model identified these regions as being the most important for predicting hypertension. The change of the branching pattern of retinal vessels was probably the most significant among a series of retinal vascular geometric characteristics changes (e.g., caliber, tortuosity, fractal dimension, branching angle) in response to elevated blood pressure. It has been assumed that the branching geometry of blood vessels is governed by definite rules and principles, including principles of minimum surface, minimum volume, minimum power, and minimum drag, which related to the physiological function of the cardiovascular system [53]. Based on these optimality principles, measurements of branching angles and the relative diameters of the vessels in arterial bifurcation mainly distributed in the optimum regions. A similar research that measured arterial bifurcations in the retina of a normal human eye and derived quantitative information supported these theoretical studies above [54]. Under different pathological conditions, such as diabetes [55, 56], branching pattern of retinal vessel should change.

One previous study used a semi-automated computer-assisted program to analyze digitized retinal photographs from a total of 1913 hypertensive patients without diabetes, and quantitatively measure the some retinal vascular parameters, including retinal vascular branching angle and retinal vascular branching asymmetry ratio [8]. The results showed that after controlling for other confounding factors, retinal arteriolar branching asymmetry ratios (the ratio of the square of the two branching vessel widths) were independently associated with mean arterial blood pressure, while arteriolar/venular branching angle and venular branching asymmetry ratio were not related to blood pressure. However, in our heat maps, the red areas that had the strongest association with hypertension covered not only the bifurcation of the arteries, but also the veins. That's probably because the segmented images lost color information, and thus unable to classify arteries and veins. For the same reason, some vessel crossings were found to be activated in heat maps. In future work, we will use images that contain only retinal arteriole or venule to construct CNN models to classify hypertension.

Recently, Poplin’s research group analyzed datasets from the UK Biobank and EyePACS cohorts using deep learning methods [46]. They trained neural networks to predict known cardiovascular risk factors such as smoking status, systolic blood pressure (SBP). The results showed that the predicted SBP increased linearly with actual SBP until approximately 150 mmHg, but leveled off above that value. They used soft attention to identify the anatomical regions that the model might have been using to make its predictions, and blood vessels were highlighted in the models trained to predict SBP. Our study provided further evidence that the effect of hypertension on retinal microvascular morphology mainly occurred at branching of arterioles. The geometry of retinal arterioles at or near arterial branching may clearly be a factor in the incidence of certain arterial lesions at such junctions.

Conclusions

The results of this study suggested that the change of the branching pattern of retinal vessel was probably the most significant in response to elevated blood pressure.

Data Availability

The data underlying this study have been uploaded to DRYAD and are accessible using the following doi: https://doi.org/10.5061/dryad.280gb5mmh.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Organization WH. The top 10 causes of death 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
  • 2.Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of Hypertension in China: Results From the China Hypertension Survey, 2012–2015. Circulation. 2018;137(22):2344–56. Epub 2018/02/17. 10.1161/CIRCULATIONAHA.117.032380 . [DOI] [PubMed] [Google Scholar]
  • 3.Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation. 2000;101(14):1653–9. Epub 2000/04/12. 10.1161/01.cir.101.14.1653 . [DOI] [PubMed] [Google Scholar]
  • 4.Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens. 2004;17(12 Pt 1):1192–200. Epub 2004/12/21. 10.1016/j.amjhyper.2004.05.023 . [DOI] [PubMed] [Google Scholar]
  • 5.Struijker-Boudier HA, Rosei AE, Bruneval P, Camici PG, Christ F, Henrion D, et al. Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur Heart J. 2007;28(23):2834–40. Epub 2007/10/19. 10.1093/eurheartj/ehm448 . [DOI] [PubMed] [Google Scholar]
  • 6.Feihl F, Liaudet L, Waeber B. The macrocirculation and microcirculation of hypertension. Curr Hypertens Rep. 2009;11(3):182–9. Epub 2009/05/16. 10.1007/s11906-009-0033-6 . [DOI] [PubMed] [Google Scholar]
  • 7.Strain WD, Adingupu DD, Shore AC. Microcirculation on a large scale: techniques, tactics and relevance of studying the microcirculation in larger population samples. Microcirculation. 2012;19(1):37–46. Epub 2011/10/07. 10.1111/j.1549-8719.2011.00140.x . [DOI] [PubMed] [Google Scholar]
  • 8.Cheung CY, Tay WT, Mitchell P, Wang JJ, Hsu W, Lee ML, et al. Quantitative and qualitative retinal microvascular characteristics and blood pressure. J Hypertens. 2011;29(7):1380–91. Epub 2011/05/12. 10.1097/HJH.0b013e328347266c . [DOI] [PubMed] [Google Scholar]
  • 9.Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology. 1999;106(12):2269–80. Epub 1999/12/22. 10.1016/s0161-6420(99)90525-0 . [DOI] [PubMed] [Google Scholar]
  • 10.Klein R, Klein BE, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol. 1994;112(1):92–8. Epub 1994/01/01. 10.1001/archopht.1994.01090130102026 . [DOI] [PubMed] [Google Scholar]
  • 11.Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ, Nieto FJ, et al. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1999;150(3):263–70. Epub 1999/08/03. 10.1093/oxfordjournals.aje.a009997 . [DOI] [PubMed] [Google Scholar]
  • 12.Wang JJ, Mitchell P, Leung H, Rochtchina E, Wong TY, Klein R. Hypertensive retinal vessel wall signs in a general older population: the Blue Mountains Eye Study. Hypertension. 2003;42(4):534–41. Epub 2003/08/27. 10.1161/01.HYP.0000090122.38230.41 . [DOI] [PubMed] [Google Scholar]
  • 13.Wong TY, Hubbard LD, Klein R, Marino EK, Kronmal R, Sharrett AR, et al. Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol. 2002;86(9):1007–13. Epub 2002/08/20. 10.1136/bjo.86.9.1007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol. 1998;116(1):83–9. Epub 1998/01/28. 10.1001/archopht.116.1.83 . [DOI] [PubMed] [Google Scholar]
  • 15.Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD. Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci. 2003;44(11):4644–50. Epub 2003/10/28. 10.1167/iovs.03-0079 . [DOI] [PubMed] [Google Scholar]
  • 16.Leung H, Wang JJ, Rochtchina E, Tan AG, Wong TY, Klein R, et al. Relationships between age, blood pressure, and retinal vessel diameters in an older population. Invest Ophthalmol Vis Sci. 2003;44(7):2900–4. Epub 2003/06/26. 10.1167/iovs.02-1114 . [DOI] [PubMed] [Google Scholar]
  • 17.Sun C, Liew G, Wang JJ, Mitchell P, Saw SM, Aung T, et al. Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study. Invest Ophthalmol Vis Sci. 2008;49(5):1784–90. Epub 2008/04/26. 10.1167/iovs.07-1450 . [DOI] [PubMed] [Google Scholar]
  • 18.Mitchell P, Cheung N, de Haseth K, Taylor B, Rochtchina E, Islam FM, et al. Blood pressure and retinal arteriolar narrowing in children. Hypertension. 2007;49(5):1156–62. Epub 2007/03/21. 10.1161/HYPERTENSIONAHA.106.085910 . [DOI] [PubMed] [Google Scholar]
  • 19.Gopinath B, Wang JJ, Kifley A, Tan AG, Wong TY, Mitchell P. Influence of blood pressure and body mass index on retinal vascular caliber in preschool-aged children. J Hum Hypertens. 2013;27(9):523–8. Epub 2013/03/02. 10.1038/jhh.2013.15 . [DOI] [PubMed] [Google Scholar]
  • 20.Li LJ, Cheung CY, Liu Y, Chia A, Selvaraj P, Lin XY, et al. Influence of blood pressure on retinal vascular caliber in young children. Ophthalmology. 2011;118(7):1459–65. Epub 2011/03/30. 10.1016/j.ophtha.2010.12.007 . [DOI] [PubMed] [Google Scholar]
  • 21.Gopinath B, Baur LA, Wang JJ, Teber E, Liew G, Cheung N, et al. Blood pressure is associated with retinal vessel signs in preadolescent children. J Hypertens. 2010;28(7):1406–12. Epub 2010/04/23. 10.1097/HJH.0b013e3283395223 . [DOI] [PubMed] [Google Scholar]
  • 22.Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P. Impact of current and past blood pressure on retinal arteriolar diameter in an older population. J Hypertens. 2004;22(8):1543–9. Epub 2004/07/17. 10.1097/01.hjh.0000125455.28861.3f . [DOI] [PubMed] [Google Scholar]
  • 23.Liew G, Wang JJ, Cheung N, Zhang YP, Hsu W, Lee ML, et al. The retinal vasculature as a fractal: methodology, reliability, and relationship to blood pressure. Ophthalmology. 2008;115(11):1951–6. Epub 2008/08/12. 10.1016/j.ophtha.2008.05.029 . [DOI] [PubMed] [Google Scholar]
  • 24.Cheung CY, Zheng Y, Hsu W, Lee ML, Lau QP, Mitchell P, et al. Retinal vascular tortuosity, blood pressure, and cardiovascular risk factors. Ophthalmology. 2011;118(5):812–8. Epub 2010/12/15. 10.1016/j.ophtha.2010.08.045 . [DOI] [PubMed] [Google Scholar]
  • 25.Cheung CY, Thomas GN, Tay W, Ikram MK, Hsu W, Lee ML, et al. Retinal vascular fractal dimension and its relationship with cardiovascular and ocular risk factors. Am J Ophthalmol. 2012;154(4):663–74 e1. Epub 2012/07/31. 10.1016/j.ajo.2012.04.016 . [DOI] [PubMed] [Google Scholar]
  • 26.Sng CC, Wong WL, Cheung CY, Lee J, Tai ES, Wong TY. Retinal vascular fractal and blood pressure in a multiethnic population. J Hypertens. 2013;31(10):2036–42. Epub 2013/06/22. 10.1097/HJH.0b013e328362c201 . [DOI] [PubMed] [Google Scholar]
  • 27.Kurniawan ED, Cheung N, Cheung CY, Tay WT, Saw SM, Wong TY. Elevated blood pressure is associated with rarefaction of the retinal vasculature in children. Invest Ophthalmol Vis Sci. 2012;53(1):470–4. Epub 2011/12/30. 10.1167/iovs.11-8835 . [DOI] [PubMed] [Google Scholar]
  • 28.Liew G, Sharrett AR, Wang JJ, Klein R, Klein BE, Mitchell P, et al. Relative importance of systemic determinants of retinal arteriolar and venular caliber: the atherosclerosis risk in communities study. Arch Ophthalmol. 2008;126(10):1404–10. Epub 2008/10/15. 10.1001/archopht.126.10.1404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD. Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ. 2004;329(7457):79 Epub 2004/06/04. 10.1136/bmj.38124.682523.55 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ikram MK, Witteman JC, Vingerling JR, Breteler MM, Hofman A, de Jong PT. Retinal vessel diameters and risk of hypertension: the Rotterdam Study. Hypertension. 2006;47(2):189–94. Epub 2005/12/29. 10.1161/01.HYP.0000199104.61945.33 . [DOI] [PubMed] [Google Scholar]
  • 31.Kawasaki R, Cheung N, Wang JJ, Klein R, Klein BE, Cotch MF, et al. Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis. J Hypertens. 2009;27(12):2386–93. Epub 2009/08/15. 10.1097/HJH.0b013e3283310f7e PubMed Central PMCID: PMC2935621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Smith W, Wang JJ, Wong TY, Rochtchina E, Klein R, Leeder SR, et al. Retinal arteriolar narrowing is associated with 5-year incident severe hypertension: the Blue Mountains Eye Study. Hypertension. 2004;44(4):442–7. Epub 2004/08/11. 10.1161/01.HYP.0000140772.40322.ec . [DOI] [PubMed] [Google Scholar]
  • 33.Tanabe Y, Kawasaki R, Wang JJ, Wong TY, Mitchell P, Daimon M, et al. Retinal arteriolar narrowing predicts 5-year risk of hypertension in Japanese people: the Funagata study. Microcirculation. 2010;17(2):94–102. Epub 2010/02/19. 10.1111/j.1549-8719.2009.00006.x . [DOI] [PubMed] [Google Scholar]
  • 34.Wang JJ, Rochtchina E, Liew G, Tan AG, Wong TY, Leeder SR, et al. The long-term relation among retinal arteriolar narrowing, blood pressure, and incident severe hypertension. Am J Epidemiol. 2008;168(1):80–8. Epub 2008/05/13. 10.1093/aje/kwn100 . [DOI] [PubMed] [Google Scholar]
  • 35.Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Klein BE, et al. Retinal arteriolar diameter and risk for hypertension. Ann Intern Med. 2004;140(4):248–55. Epub 2004/02/19. 10.7326/0003-4819-140-4-200402170-00006 . [DOI] [PubMed] [Google Scholar]
  • 36.LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521(7553):436–44. Epub 2015/05/29. 10.1038/nature14539 . [DOI] [PubMed] [Google Scholar]
  • 37.Abbas Q, Fondon I, Sarmiento A, Jimenez S, Alemany P. Automatic recognition of severity level for diagnosis of diabetic retinopathy using deep visual features. Med Biol Eng Comput. 2017;55(11):1959–74. Epub 2017/03/30. 10.1007/s11517-017-1638-6 . [DOI] [PubMed] [Google Scholar]
  • 38.Abramoff MD, Lou Y, Erginay A, Clarida W, Amelon R, Folk JC, et al. Improved Automated Detection of Diabetic Retinopathy on a Publicly Available Dataset Through Integration of Deep Learning. Invest Ophthalmol Vis Sci. 2016;57(13):5200–6. Epub 2016/10/05. 10.1167/iovs.16-19964 . [DOI] [PubMed] [Google Scholar]
  • 39.Gargeya R, Leng T. Automated Identification of Diabetic Retinopathy Using Deep Learning. Ophthalmology. 2017;124(7):962–9. Epub 2017/04/01. 10.1016/j.ophtha.2017.02.008 . [DOI] [PubMed] [Google Scholar]
  • 40.Gulshan V, Peng L, Coram M, Stumpe MC, Wu D, Narayanaswamy A, et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. JAMA. 2016;316(22):2402–10. Epub 2016/11/30. 10.1001/jama.2016.17216 . [DOI] [PubMed] [Google Scholar]
  • 41.Takahashi H, Tampo H, Arai Y, Inoue Y, Kawashima H. Applying artificial intelligence to disease staging: Deep learning for improved staging of diabetic retinopathy. PLoS One. 2017;12(6):e0179790 Epub 2017/06/24. 10.1371/journal.pone.0179790 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Voets M, Mollersen K, Bongo LA. Reproduction study using public data of: Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. PLoS One. 2019;14(6):e0217541 Epub 2019/06/07. 10.1371/journal.pone.0217541 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Burlina PM, Joshi N, Pekala M, Pacheco KD, Freund DE, Bressler NM. Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks. JAMA Ophthalmol. 2017;135(11):1170–6. Epub 2017/10/04. 10.1001/jamaophthalmol.2017.3782 PubMed Central PMCID: PMC5710387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779 Epub 2015/04/01. 10.1371/journal.pmed.1001779 PubMed Central PMCID: PMC4380465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Cuadros J, Bresnick G. EyePACS: an adaptable telemedicine system for diabetic retinopathy screening. J Diabetes Sci Technol. 2009;3(3):509–16. Epub 2010/02/11. 10.1177/193229680900300315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Poplin R, Varadarajan AV, Blumer K, Liu Y, McConnell MV, Corrado GS, et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nat Biomed Eng. 2018;2(3):158–64. Epub 2019/04/25. 10.1038/s41551-018-0195-0 . [DOI] [PubMed] [Google Scholar]
  • 47.Pizer SM, Amburn EP, Austin JD, Cromartie R, Geselowitz A, Greer T, et al. Adaptive histogram equalization and its variations. Computer Vision, Graphics, and Image Processing. 1987;39(3):355–68. 10.1016/S0734-189X(87)80186-X. [DOI] [Google Scholar]
  • 48.Siebert A. Differential invariants under gamma correction 2000. Available from: https://arxiv.org/abs/cs/0003079.
  • 49.Antiga L. Retina blood vessel segmentation with a convolution neural network (U-net) 2016. Available from: https://github.com/orobix/retina-unet#retina-blood-vessel-segmentation-with-a-convolution-neural-network-u-net.
  • 50.Ronneberger O, Fischer P, Brox T, editors. U-Net: Convolutional Networks for Biomedical Image Segmentation2015; Cham: Springer International Publishing. [Google Scholar]
  • 51.Staal J, Abramoff MD, Niemeijer M, Viergever MA, van Ginneken B. Ridge-based vessel segmentation in color images of the retina. IEEE Trans Med Imaging. 2004;23(4):501–9. Epub 2004/04/16. 10.1109/TMI.2004.825627 . [DOI] [PubMed] [Google Scholar]
  • 52.Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, Batra D, editors. Grad-cam: Visual explanations from deep networks via gradient-based localization. Proceedings of the IEEE International Conference on Computer Vision; 2017. [Google Scholar]
  • 53.Zamir M. Optimality principles in arterial branching. J Theor Biol. 1976;62(1):227–51. Epub 1976/10/07. 10.1016/0022-5193(76)90058-8 . [DOI] [PubMed] [Google Scholar]
  • 54.Zamir M, Medeiros JA, Cunningham TK. Arterial bifurcations in the human retina. J Gen Physiol. 1979;74(4):537–48. Epub 1979/10/01. 10.1085/jgp.74.4.537 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Li LJ, Lamoureux E, Wong TY, Lek N. Short-term poor glycemic control and retinal microvascular changes in pediatric Type 1 Diabetes patients in Singapore: a pilot study. BMC Ophthalmol. 2017;17(1):60 Epub 2017/06/16. 10.1186/s12886-017-0449-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sasongko MB, Wang JJ, Donaghue KC, Cheung N, Benitez-Aguirre P, Jenkins A, et al. Alterations in retinal microvascular geometry in young type 1 diabetes. Diabetes Care. 2010;33(6):1331–6. Epub 2010/03/20. 10.2337/dc10-0055 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Frank T Spradley

16 Jan 2020

PONE-D-19-32450

Exploring the effect of hypertension on retinal microvasculature using deep learning on East Asian population: A pilot study employing small database

PLOS ONE

Dear Prof He,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

SPECIFIC ACADEMIC EDITOR COMMENTS: An expert in the field reviewed this manuscript. There was much interest in this study. However, a comment was made about the small sample size. A goal of PLOS ONE is to publish studies of rigorous experimental design, not necessarily "pilot studies" that may not be reproducible. An attempt should be made to increase the sample size to make this less of a pilot study.

We would appreciate receiving your revised manuscript by Mar 01 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Frank T. Spradley

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Study title: Exploring the effect of hypertension on retinal microvasculature using deep learning on East Asian population: A pilot study employing small database

The study looks good attempt as a pilot study. But it has limitations of low sample size and low sensitivity and specificity.

I have no further comments.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Raba Thapa MD, PhD

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review comments.docx

PLoS One. 2020 Mar 5;15(3):e0230111. doi: 10.1371/journal.pone.0230111.r002

Author response to Decision Letter 0


8 Feb 2020

For the problem about the small sample size, we collected another 407 retinal photographs from patients with a diagnosis of hypertension and 405 retinal photographs from normotensive patients. There were 2012 retinal images including 1007 hypertension images and 1005 non-hypertension images in our study. The dataset size, however, was small for deep learning. So we use some strategies, such as reducing the size of the model, using dropout layers and data augmentation, to mitigate overfitting and maximize generalization. After increasing sample size, for “segmented dataset” the evaluation parameters (accuracy, specificity, precision, recall, the area under the receiver operating characteristic curve) changed little, while for “enhanced dataset” the change was comparatively large, as shown in the following table. The possible reason was that images from “segmented dataset” contained only retinal microvasculature and the information of leading the model to hypertension decision mainly came from retinal microvasculature. But images from “enhanced dataset” contained a lot of additional information besides retinal microvasculature and the model learns representations that are not specific to hypertension. Accordingly we inferred that with increasing sample size, for “segmented dataset” the result will not be much different.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Frank T Spradley

24 Feb 2020

Exploring the effect of hypertension on retinal microvasculature using deep learning on East Asian population

PONE-D-19-32450R1

Dear Dr. He,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Frank T. Spradley

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I congratulate the authors for good attempt. The addition of more pictures have made the outcome better.

I have no comments for this manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Frank T Spradley

27 Feb 2020

PONE-D-19-32450R1

Exploring the effect of hypertension on retinal microvasculature using deep learning on East Asian population

Dear Dr. He:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Frank T. Spradley

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Review comments.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The data underlying this study have been uploaded to DRYAD and are accessible using the following doi: https://doi.org/10.5061/dryad.280gb5mmh.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES